Drug therapy advances have slashed the rate of hypos: study

Danish data highlight the relatively greater risk with use of human insulins and sulfonylureas, researchers say
Clare Pain
ED sign

Development of insulin analogues and newer drug classes for diabetes likely lie behind a fall of more than 60% in hospital admissions for hypoglycaemia, Danish researchers say.

Among patients with type 2 diabetes, the move away from sulfonylureas to metformin, DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors has increased patient safety, their study suggests.